TurnKey Covid PCR Lab Solutions

• Urinary Tract Infections (UTI) are difficult to diagnose because there are vague symptoms and often infections. An inaccurate diagnosis can lead to serious consequences.
• In fact, typical urine culture misses up around two thirds of all UTI-positive patients.
• Additionally, the introduction of Multi-Drug Resistant Organisms (MDROs), oftentimes referred as antibiotic resistance, has made the treatment of UTIs much more challenging.
• That is why it is critical to correctly and rapidly identify the infecting pathogens and exclude antibiotic resistance.

The Respiratory Pathogen Panel  is Target Enriched Multiplex Polymerase Chain Reaction) technology - a multiplex PCR amplification technology to detect multiple targets simultaneously. PCR helps identify co-infections, provides physicians with valuable diagnostic insight into unknown causes of infection, reduces unnecessary antibiotic administration and hospital acquired infections, allows for molecular testing in patients with concurrent antibiotic use, and more targeted therapy for better patient management and overall reduced hospital costs.

About Respiratory Pathogen Panel

This assay detects the majority of respiratory disease-causing viral and bacterial pathogens of critical importance to patients, including children, elderly, and the immunocompromised. An etiologic diagnosis of respiratory disease will lead to more effective and efficient management of patients, and play a key role in supporting Healthcare Reform and Antimicrobial Stewardship — helping to facilitate the CDC’s efforts to cross-communicate antibiotic-resistant bacteria data across the U.S. — to ultimately decrease the spread of infections and combat the increasingly devastating effects of “superbugs.”